| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | B |
| 4. Measurand | C |
| 5. Pre-Analytical | B |
| 6. Replicate Analysis | A |
| 7. Steady State | A |
| 8. Outlier Analysis | C |
| 9. Normality | A |
| 10. Variance Homogeneity | C |
| 11. ANOVA | A |
| 12. CI | A |
| 13. No of Results | A |
| 14. Concentrations | A |
| 15. Total Score | C4,8,10 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Plasma |
| Measurand | Suppression of tumorigenicity 2 (ST2) |
| Unit | ng / mL |
| Overall Analytical Principle Method | Immunoassay; ELISA |
| Number of Subjects | 28 |
| Number of Subjects included in BV estimation | 28 |
| Ethinicity | Unknown |
| Age Mean / Median | 43.0 |
| Age Min | |
| Age Max | |
| Age SD | 13.0 |
| Number of Males | 14 |
| Number of Females | 14 |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 4 |
| Study Duration Units | Week |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
| Interval Units | Week |
| Sampling Times | Start Time:
End Time: |
| Number of Samples | 5 |
| Average Number of Samples Used for BV Estimation | 5.0 |
| Average Number of Replicates | |
| Estimates of CVi | 10.5 |
| Calculated Confidence Intervals of CVi | Lower: 9.10, Upper: 12.19 |
| Estimates of CVg | 30.4 |
| Calculated Confidence Intervals of CVg | Lower: 23.94, Upper: 41.35 |
| Analytical CV | 2.9 |
| Calculated Confidence Intervals of Analytical CV | Lower: 2.12, Upper: 4.57 |
| Measurand Mean | 22.0 |
| Measurand Min | 19.6 |
| Measurand Max | 27.4 |
| Measurand SD |